225 related articles for article (PubMed ID: 3113776)
1. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers.
Kendall-Taylor P; Stephenson A; Stratton A; Papiha SS; Perros P; Roberts DF
Clin Endocrinol (Oxf); 1988 Jun; 28(6):601-10. PubMed ID: 3254259
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
5. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens.
Balazs C; Bokk A; Molnar I; Stenszky V; Farid NR
Exp Clin Immunogenet; 1989; 6(2):190-2. PubMed ID: 2629892
[No Abstract] [Full Text] [Related]
7. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease.
Frecker M; Mercer G; Skanes VM; Farid NR
Autoimmunity; 1988; 1(4):307-15. PubMed ID: 2979624
[TBL] [Abstract][Full Text] [Related]
8. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
10. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
[TBL] [Abstract][Full Text] [Related]
11. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
12. C4A gene deletion: association with Graves' disease.
Ratanachaiyavong S; Lloyd L; McGregor AM
J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetics of Graves' ophthalmopathy.
Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
[TBL] [Abstract][Full Text] [Related]
14. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
Kozma L; Stenszky V; Kraszits E; Balazs C; Farid NR
Exp Clin Immunogenet; 1985; 2(3):154-7. PubMed ID: 3939975
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease.
Jacobson DR; Fleming BJ
Am J Med Sci; 1984 Dec; 288(5):217-20. PubMed ID: 6334992
[TBL] [Abstract][Full Text] [Related]
16. The operation of immunological networks in Graves' disease.
Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
[TBL] [Abstract][Full Text] [Related]
17. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
[TBL] [Abstract][Full Text] [Related]
18. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
Farid NR; Barnard JM; Marshall WH
Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic markers in patients with Graves' disease.
Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.
van der Gaag R; Wiersinga WM; Koornneef L; Mourits MP; Prummel MF; Berghout A; de Vries RR; Schreuder GM; D'Amaro J
J Endocrinol Invest; 1990 Jun; 13(6):489-92. PubMed ID: 2258577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
